Mid-Atlantic Bio

Presenting Companies Announced for 2009 Mid-Atlantic Bio Conference

Twenty-Four Companies from across the Region Representing Biotech, Biopharmaceutical Drug Development and Discovery, Devices, and Vaccine Sectors

Nine later-stage growth companies and 15 emerging companies will present before an audience of life science investors and industry professionals at the 2009 Mid-Atlantic Bio Conference. 

Showcase Track, later stage companies, includes:

* Arginetix, Inc., Baltimore, Md.
* Cylex, Inc., Columbia, Md.
* Intrexon Corporation, Blacksburg, Va.
* OpGen Inc., Gaithersburg, Md.
* Cardioxyl Pharmaceuticals, Raleigh, N.C.
* HemoShear, Charlottesville, Va.
* OcuCure Therapeutics, Roanoke, Va.
* openQ, Charlottesville, Va.
* Promedior, Melvern, Pa.

Growth Watch Track, emerging companies, includes:

* ADial Pharmaceuticals, Inc., Charlottesville, Va.
* BC Genesis LLC, Blacksburg, Va.
* Celek Pharmaceuticals, Darnestown, Md.
* ContraVac, Inc., Charlottesville, Va.
* Dalos BioPharma, Virginia Beach, Va.
* DioGenix, Gaithersburg, Md.
* EpiEP, Inc., Charlottesville, Va.
* Extinction Pharmaceuticals, Inc., Williamsburg, Va.
* Gliknik Inc., Baltimore, Md.
* Immunomic Therapeutics, Inc., Gaithersburg, Md.
* Inhibikase Therapeutics, Smyrna, Ga.
* Phthisis Diagnostics, Charlottesville, Va.
* Principio Inc., Rockville, Md.
* Profectus BioSciences, Inc., Baltimore, Md.
* Synthonics, Blacksburg, Va.

Each year, a limited number of life science companies are invited to present before an audience of capital sources, including venture capitalists, angel investors, and various other qualified financing sources, along with more than 850 conference attendees. For this year’s conference, two distinct tracks will be featured: Showcase (later-stage growth companies) and Growth Watch (emerging companies). 

“In building on last year’s success, we continue to offer a broad platform that encourages investor interest, innovation review, and industry collaboration,” said Host committee member Julia Spicer, executive director, Mid-Atlantic Venture Association (MAVA).  “This year’s lineup includes some of the most outstanding company representatives in a growing, vibrant community in the Mid-Atlantic region.”

Presenting companies were chosen through an industry review process with input from more than 40 investment institutions and industry professionals.

Contact:

For additional information on presenting at the conference, please contact Kathy O’Laughlin at kathy@mava.org. telephone (410) 560-5855.